Literature DB >> 23707719

Id1 expression promotes peripheral CD4+ T cell proliferation and survival upon TCR activation without co-stimulation.

Chen Liu1, Rong Jin, Hong-Cheng Wang, Hui Tang, Yuan-Feng Liu, Xiao-Ping Qian, Xiu-Yuan Sun, Qing Ge, Xiao-Hong Sun, Yu Zhang.   

Abstract

Although the role of E proteins in the thymocyte development is well documented, much less is known about their function in peripheral T cells. Here we demonstrated that CD4 promoter-driven transgenic expression of Id1, a naturally occurring dominant-negative inhibitor of E proteins, can substitute for the co-stimulatory signal delivered by CD28 to facilitate the proliferation and survival of naïve CD4+ cells upon anti-CD3 stimulation. We next discovered that IL-2 production and NF-κB activity after anti-CD3 stimulation were significantly elevated in Id1-expressing cells, which may be, at least in part, responsible for the augmentation of their proliferation and survival. Taken together, results from this study suggest an important role of E and Id proteins in peripheral T cell activation. The ability of Id proteins to by-pass co-stimulatory signals to enable T cell activation has significant implications in regulating T cell immunity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707719      PMCID: PMC3955101          DOI: 10.1016/j.bbrc.2013.05.054

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities.

Authors:  Dongsoo Kim; Min Xu; Lei Nie; Xiao-Cong Peng; Eijiro Jimi; Reinhard E Voll; Thuan Nguyen; Sankar Ghosh; Xiao-Hong Sun
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

3.  Characterization of transcriptional regulation during negative selection in vivo.

Authors:  Deborah DeRyckere; Derrick L Mann; James DeGregori
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

Review 4.  Multitasking of helix-loop-helix proteins in lymphopoiesis.

Authors:  Xiao-Hong Sun
Journal:  Adv Immunol       Date:  2004       Impact factor: 3.543

Review 5.  Jurkat T cells and development of the T-cell receptor signalling paradigm.

Authors:  Robert T Abraham; Arthur Weiss
Journal:  Nat Rev Immunol       Date:  2004-04       Impact factor: 53.106

6.  A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes.

Authors:  P J Martin; J A Ledbetter; Y Morishita; C H June; P G Beatty; J A Hansen
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

7.  Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB.

Authors:  R J Barndt; M Dai; Y Zhuang
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade.

Authors:  G Bain; C B Cravatt; C Loomans; J Alberola-Ila; S M Hedrick; C Murre
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

9.  Hyperresponse to T-cell receptor signaling and apoptosis of Id1 transgenic thymocytes.

Authors:  Zengbiao Qi; Xiao-Hong Sun
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  Early thymocyte development is regulated by modulation of E2A protein activity.

Authors:  I Engel; C Johns; G Bain; R R Rivera; C Murre
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  1 in total

1.  Id1 expression promotes T regulatory cell differentiation by facilitating TCR costimulation.

Authors:  Chen Liu; Hong-Cheng Wang; Sen Yu; Rong Jin; Hui Tang; Yuan-Feng Liu; Qing Ge; Xiao-Hong Sun; Yu Zhang
Journal:  J Immunol       Date:  2014-06-11       Impact factor: 5.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.